Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies.
about
The optimal duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents: an unanswered question.Biodegradable polymer drug-eluting stents versus first-generation durable polymer drug-eluting stents: A systematic review and meta-analysis of 12 randomized controlled trials.Efficacy and safety of adding rivaroxaban to the anti-platelet regimen in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.Impact of right coronary dominance on triple-vessel coronary artery disease: A cross-sectional study
P2860
Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Should a prolonged duration of ...... d meta-analysis of 15 studies.
@ast
Should a prolonged duration of ...... d meta-analysis of 15 studies.
@en
type
label
Should a prolonged duration of ...... d meta-analysis of 15 studies.
@ast
Should a prolonged duration of ...... d meta-analysis of 15 studies.
@en
prefLabel
Should a prolonged duration of ...... d meta-analysis of 15 studies.
@ast
Should a prolonged duration of ...... d meta-analysis of 15 studies.
@en
P2093
P2860
P31
P1476
Should a prolonged duration of ...... d meta-analysis of 15 studies.
@en
P2093
Chandra Mouli Yanamala
Feng Huang
Pravesh Kumar Bundhun
P2860
P2888
P356
10.1186/S12872-016-0343-Y
P5008
P577
2016-08-30T00:00:00Z
P6179
1002038990